Facilities Overview SEATTLE BOULDER LONGMONT COPENHAGEN HEIDELBERG MILAN CHIBA WE'RE HERE FOR YOU, WHEREVER YOU ARE Seattle, Washington, USA MAMMALIAN MICROBIAL (Q2–2021) Boulder, Colorado, USA MAMMALIAN Longmont, Colorado, USA CELL THERAPY VIRAL VECTORS GENE THERAPY Copenhagen, Denmark MAMMALIAN MICROBIAL Heidelberg, Germany MICROBIAL PLASMID DNA Milan, Italy CELL THERAPY VIRAL VECTORS Chiba, Japan MAMMALIAN MICROBIAL ABOUT CAPABILITIES RESOURCES FACILITIES NEWS & EVENTS LEGAL & COMPLIANCE CONTACT US Follow us on LinkedIn Follow us on Twitter Follow us on Facebook NEWS AGC Biologics Appoints Jean-Baptiste Agnus as Chief Business Officer AGC Biologics Expands pDNA and mRNA Manufacturing Capacity AGC Biologics Announces the Groundbreaking of its New Facility at its Copenhagen, Denmark Site AGC Biologics Appoints Tony Fraij as the new General Manager/Site Head of the Longmont, Colorado Site AGC Biologics Acquires Commercial Facility, Expanding Cell & Gene Therapy Global Service Offerings EVENTS Cell & Gene Meeting on the Mesa, October 12-14, 2021 AGC Biologics is Attending BIO Asia-Taiwan July 23-26, 2021 Presenting Our Biological and Cell & Gene Therapy Capabilities AGC Biologics is Attending ASGCT May 11-14, 2021 and Presenting Our Scalable LVV Production Process and Large-Scale AAV Manufacturing Development Data AGC Biologics is Attending Meeting on the Med, April 6-9, 2021 FACILITIES SEATTLE, WASHINGTON (Headquarters) BOULDER, COLORADO LONGMONT, COLORADO COPENHAGEN, DENMARK HEIDELBERG, GERMANY MILAN, ITALY CHIBA, JAPAN ©2021 AGC Biologics. All Rights Reserved. Website Privacy Policy